Similar articles

• Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice.

  Natolino F, Zanotti A, Contarino A, Lipartiti M, Giusti P. Natolino F, et al. Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):612-7. doi: 10.1007/BF00170836. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8938660
• Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil.

  Löscher W, Hönack D. Löscher W, et al. Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):452-60. doi: 10.1007/BF00176624. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1352384
• Behavioral pharmacology of abecarnil in baboons: reduced dependence and abuse potential.

  Sannerud CA, Ator NA, Griffiths RR. Sannerud CA, et al. Psychopharmacol Ser. 1993;11:113-20. doi: 10.1007/978-3-642-78451-4_9. Psychopharmacol Ser. 1993. PMID: 7908430 No abstract available.
• Time course for development of benzodiazepine tolerance and physical dependence.

  Rosenberg HC, Chiu TH. Rosenberg HC, et al. Neurosci Biobehav Rev. 1985 Spring;9(1):123-31. doi: 10.1016/0149-7634(85)90038-7. Neurosci Biobehav Rev. 1985. PMID: 2858077 Review.
• Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedation.

  Stephens DN, Turski L, Jones GH, Steppuhn KG, Schneider HH. Stephens DN, et al. Psychopharmacol Ser. 1993;11:79-95. doi: 10.1007/978-3-642-78451-4_7. Psychopharmacol Ser. 1993. PMID: 7908435 Review. No abstract available.